Stroke News

A new study identified COVID-19 as an independent risk factor for acute MI and ischemic stroke.

A transport policy for emergency medical services resulted in a substantial and swift increase in rates of endovascular therapy after acute ischemic stroke, according to findings from a single-center study published in JAMA Neurology.

Abbott announced the FDA approval of its left atrial appendage occlusion device for the treatment of atrial fibrillation in patients at risk for ischemic stroke.

Physical activity correlated with decreased all-cause mortality in a dose-dependent matter among individuals with a history of stroke, especially younger individuals, according to findings published in Neurology.

Studies showed that low enrollment of women in CVD clinical trials may be influenced by myriad clinical, racial and community-related factors, according to a perspective published in the Journal of the American College of Cardiology.

Among patients with stroke who presented early after symptom onset, those treated by a mobile stroke unit were more functionally independent at 90 days compared with those treated with the “drip and ship” method, researchers reported.

Direct transfer to an angiography suite within 6 hours of stroke onset increased rates of endovascular therapy, reduced hospital workflow time and enhanced clinical outcomes, according to findings published in JAMA Neurology.

Among patients with ischemic stroke and mismatch imaging profiles, the performance of endovascular thrombectomy correlated with improvements in clinical outcomes, according to a study published in JAMA Neurology.

Lumosa Therapeutics announced its novel agent for patients with acute ischemic stroke met the primary safety endpoint in a phase 2 trial.

Healio and Cardiology Today have aggregated a list of the most-read news in cardiology of July 2021.